Growth in Vertebroplasty Market Still Strong as New Players Enter Market

U.S. market to grow at double digit rates over the next 5 years.

Waltham, MA (PRWEB) July 2, 2007 -- Millennium Research Group (MRG) has conducted a detailed analysis of the minimally invasive vertebral compression fracture (VCF) treatment market in its Global Markets for Minimally Invasive Vertebral Compression Fracture Treatments 2007 report. The analysis reveals that the US market will continue its robust expansion over the forecast period buoyed by the popularity of kyphoplasty and the emergence of new devices and competitors in the vertebroplasty market. Valued at approximately $365 million in 2006, the US minimally invasive VCF treatment market will be valued at more than $650 million by 2011.

"Currently, Kyphon is the largest player in the minimally invasive VCF treatment market with its kyphoplasty products. However, all the competitors including Kyphon, Stryker, ArthroCare, Cardinal Health, and Cook continue to improve the safety, efficacy, and ease-of-use of their vertebroplasty products," says Kevin Flewwelling, Senior Analyst at MRG. "Furthermore, newer competitors like Medtronic Spinal and Biologics, Spine Wave, and Spineology are providing practitioners new treatment alternatives to choose from."

Fractures in the vertebrae are primarily caused by osteoporosis -- often referred to as the "silent disease" because bone loss transpires gradually without symptoms. People may be unaware they have the disease until it has advanced to such a point that any sudden strain, bump, or fall leads to a fracture or a collapsed vertebra.

Global Markets for Minimally Invasive Vertebral Compression Fracture Treatments 2007 report includes coverage of industry competitors, including Kyphon, Stryker, ArthroCare, Cook Medical, Cardinal Health, Biomet Spine, DePuy Spine, Disc-O-Tech, Medtronic Spinal and Biologics, Spine Wave, and Spineology.

About Minimally Invasive Vertebral Compression Fracture Treatments:

Vertebroplasty and kyphoplasty are minimally invasive, nonsurgical procedures designed to relieve the pain caused by vertebral compression fractures. Both procedures involve the insertion of a special bone needle through the posterior soft tissues and the injection of a small amount of orthopedic cement through the needle into the vertebral body. Additionally, kyphoplasty involves two proprietary balloon devices, which are inserted into the vertebral body and gradually inflated, thereby restoring it to its prefracture shape and height.

About Millennium Research Group:

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

###